LifeSci Communications

Global communications and marketing agency focused on #LifeSciences and #MedTech companies.

[DiaMedica Therapeutics @diamedica]

.@NPR spoke with Professor @CathyCluver, principal investigator of DiaMedica’s Phase 2 study, about the potential of DM199 for the treatment of #preeclampsia and her insights from the ongoing study. Read more: https://t.co/PLZv25V6wK

[LifeSci Communications @LifeSciComms]

Dr. Tom Heineman, CMO of our client @Oncolytics, joined an episode of Drug Delivery Leader’s Sit and Deliver series to share how its intravenously administered immunotherapy has the potential to treat several types of #cancer. Watch here: https://t.co/QpQYCpaUhv

[LifeSci Communications @LifeSciComms]

Jonathan Rigby, @Sernovabio’s CEO, breaks down how the company’s Cell Pouch bio-hybrid organ has the potential to change the game for Type 1 diabetes (#T1D). Watch his interview with Diabetech to learn how Sernova is pushing toward a functional cure: https://t.co/wFEjD9Q52L

[LifeSci Communications @LifeSciComms]

Our client @LB_Pharma’s CEO Heather Turner recently spoke with @BenMComer about how her general counsel background helped shape her leadership in #biotech.

Read her insights in this Life Science Leader piece: https://t.co/peG9hpWDJ0

[LifeSci Communications @LifeSciComms]

@MeiraGTx is making groundbreaking strides in #GeneticMedicines. They recently reported their experimental #GeneTherapy provided significant improvements in the vision of 11 children who were legally blind. Read more from Alex Knapp in @Forbes: https://t.co/JEf9Yb2tQi

[LifeSci Communications @LifeSciComms]

Proposed panel “Understanding Anxiety Inside Out – Beyond the Emotions,” inspired by Pixar’s animation, would feature @mindmedco CMO, Dr. Dan Karlin using cinematic insights to engage in dialogues on mental health exploring #anxiety at #SXSW2025. Vote: https://t.co/gTUObGZV5H

[LifeSci Communications @LifeSciComms]

Through dedication to community-driven innovation, we’re proud to support several clients who submitted proposals for panels at #SXSW2025. Help bring vital scientific perspectives to the forefront by voting on SXSW’s #PanelPicker through August 18th: https://t.co/KMDYmbiERe

[LifeSci Communications @LifeSciComms]

The proposed #SXSW2025 panel “The Secret Life of DNA,” would feature @ProFoundTx CEO John Lepore and @QuotientTx co-founder Geoffrey von Maltzahn. They’d explore how recent tech allows us to study unknown regions of the #genome and what’s to come. Vote: https://t.co/PT9jdPHbrM

[LifeSci Communications @LifeSciComms]

🎉 Congratulations to our clients, @COURPharma and @ProFoundTx, for being named to the #Fierce15 list for 2024! Your dedication to #biotech innovation is inspiring. We're honored to be part of your journey! Check out the list here: https://t.co/9scSJUs5OM

[LifeSci Communications @LifeSciComms]

Fatalities are an unfortunate reality of clinical trials. How can companies best protect themselves? Our crisis comms expert & head of media Drew Levinson shares best practices via real-life examples in @biospace: https://t.co/g8CaiCusYl

[LifeSci Communications @LifeSciComms]

#ICYMI we hosted two panels at the BIO International Convention! We heard from experts on breakthrough innovations transforming the #biotech industry. Thanks to all moderators & panelists for an engaging discussion! Find panel recordings here: https://t.co/sIyAQxITZb #BIO2024

[LifeSci Communications @LifeSciComms]

Our client, @ProFoundTx, was recently featured in @statnews showcasing their first R&D collaboration with @FlagshipPioneer and @pfizer in #obesity. Check it out here: https://t.co/RpToqtJIKz

[LifeSci Communications @LifeSciComms]

Our work on Nanobiotix's corporate website earned a Web Excellence Award! See the site: https://t.co/kEbO15IvTR

[LifeSci Communications @LifeSciComms]

Exciting news! Our team won a Web Excellence Award for creating and developing Bitterroot Bio's corporate website. This achievement is the result of inspiring collaboration with the entire Bitterroot team. Check out Bitterroot's site: https://t.co/WaOTuwdtOh

[LifeSci Communications @LifeSciComms]

6 CAR-T therapies have been approved by the FDA over the last 6 years to treat #BloodCancer, but how are innovators navigating the challenges of the space? Learn from experts at a #BIO2024 panel moderated by @FiercePharma & @FierceBiotech's @Angus_Fierce: https://t.co/Y08vnKYMb3

[LifeSci Communications @LifeSciComms]

A recent study forecasts that half of the global population will experience a #MentalHealthdisorder. Learn how experts plan to tackle the next wave of innovation in drug development at our #BIO2024 panel, moderated by Heather McKenzie from @biospace: https://t.co/6LMYdjppS0